Opsis Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Opsis Therapeutics's estimated annual revenue is currently $775k per year.
- Opsis Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Opsis Therapeutics has 5 Employees.
- Opsis Therapeutics grew their employee count by 0% last year.
Opsis Therapeutics's People
Name | Title | Email/Phone |
---|
Opsis Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Opsis Therapeutics?
Retinal degenerative diseases cause irreversible vision loss in tens of millions of patients worldwide. Our mission at Opsis Therapeutics is to advance a pipeline of best-in-class cell replacement therapies targeting Age Related Macular Degeneration (‘AMD’) and inherited retinal diseases including Retinitis Pigmentosa (‘RP’). Our technology platform builds upon recent advances that enable scalable manufacture of authentic human retinal cells from induced-pluripotent stem cells (‘iPSCs’).
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | -37% | N/A |
#2 | $0.5M | 5 | 25% | N/A |
#3 | $0.4M | 5 | 0% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | 0% | N/A |